Skip to main content

Peer Review reports

From: The residual cancer burden index as a valid prognostic indicator in breast cancer after neoadjuvant chemotherapy

Original Submission
18 Jul 2023 Submitted Original manuscript
28 Aug 2023 Reviewed Reviewer Report
30 Aug 2023 Reviewed Reviewer Report - Guoyi Jiang
28 Sep 2023 Author responded Author comments - Zhiyong Yu
Resubmission - Version 2
28 Sep 2023 Submitted Manuscript version 2
6 Oct 2023 Author responded Author comments - Zhiyong Yu
Resubmission - Version 3
6 Oct 2023 Submitted Manuscript version 3
26 Oct 2023 Reviewed Reviewer Report
27 Oct 2023 Reviewed Reviewer Report - Guoyi Jiang
14 Nov 2023 Author responded Author comments - Zhiyong Yu
Resubmission - Version 4
14 Nov 2023 Submitted Manuscript version 4
Publishing
5 Dec 2023 Editorially accepted
2 Jan 2024 Article published 10.1186/s12885-023-11719-z

You can find further information about peer review here.

Back to article page